Jing Lin
- Molecular Biology top 10%
- Cancer Research top 5%
- Oncology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Pharmacology top 10%
- Co-authors
- Qinong YeJing‐Gung ChungLihua DingJai‐Sing YangLong ChengKai JiangXiaojie XuGuang Wei Chen
- Topics
- Lung Cancer Treatments and Mutations (9 papers)Cancer Genomics and Diagnostics (8 papers)Cancer, Hypoxia, and Metabolism (8 papers)
- Journals
- Journal of Biological ChemistryJournal of Clinical InvestigationJournal of Clinical Oncology
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Jing Lin
60 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 116
- Molecular Biology 1.1k
- Cancer Research 522
- Oncology 374
- Pulmonary and Respiratory Medicine 215
- Pharmacology 168
Countries citing papers authored by Jing Lin
This map shows the geographic impact of Jing Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Lin more than expected).
Fields of papers citing papers by Jing Lin
This network shows the impact of papers produced by Jing Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Lin. The network helps show where Jing Lin may publish in the future.
Co-authorship network of co-authors of Jing Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Jing Lin. A scholar is included among the top collaborators of Jing Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Lin. Jing Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 5 | |
| 6 | 0 | |
| 7 | 15 | |
| 8 | 8 | |
| 9 | 4 | |
| 10 | 1 | |
| 11 | 35 | |
| 12 | 4 | |
| 13 | Bisdemethoxycurcumin (BDMC) Alters Gene Expression-associated Cell Cycle, Cell Migration and Invasion and Tumor Progression in Human Lung Cancer NCI-H460 Cells. | 7 |
| 14 | 26 | |
| 15 | 225 | |
| 16 | 24 | |
| 17 | 17 | |
| 18 | 65 | |
| 19 | 48 | |
| 20 | 53 |
About Jing Lin
Jing Lin is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 67 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (9 papers), Cancer Genomics and Diagnostics (8 papers) and Cancer, Hypoxia, and Metabolism (8 papers). The work is most often cited by research in Cancer Research (522 citations), Toxicology (57 citations) and Molecular Biology (1.1k citations). Jing Lin has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Qinong Ye, Jing‐Gung Chung, Lihua Ding, Jai‐Sing Yang, Long Cheng, Kai Jiang, Xiaojie Xu, Lihua Ding, Guang Wei Chen and Chin Chung Lin. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.